AcelRx (ACRX)

Latest Trade: $3.60

IPO News

AcelRx quiet period ends March 22 3/17/11
AcelRx prices IPO at $5, below the original $12-$14 range 2/11/11
AcelRx slashes proposed IPO price to $5 per share, now plans to raise $40 million 2/9/11
11 IPOs planned for the week of Feb 7 2/7/11
12 IPOs planned for the week of Jan 31 1/31/11
Biotech AcelRx sets IPO terms 1/20/11
Biotech AcelRx files for $86 million IPO 11/12/10

Performance History

Interested in IPO Investing?

First Day Return
4.5500

-9.0%
Aftermarket Return
4.5500

-20.9%
Return from IPO
5.0000

-28.0%

IPO Date
02/10/11
Offer Price
$5.00
Offer Shares
8.0 mm
Lead Manager(s)
Piper Jaffray
Co Manager(s)
Canaccord Genuity

All Underwriters

Business

Business
Biotech developing a Phase 3 treatment for acute post-operative pain.
Industry
Health-Drugs
Employees
19
Founded
2005

ACRX Daily

Chart

Corporate Data

Company Address
575 Chesapeake Drive
Redwood City, CA
Phone Number
(650) 216-3500
Web Address
www.acelrx.com